|  | All subjects (n = 83) | VL ≥ median (n = 42) | VL < median (n = 41) |  |  | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Variables | Units | N | Mean | SD | N | Mean | SD | N | Mean | SD | unadjusted p * | FDR q** |
Age | years | 83 | 34.5 | 8.2 | 42 | 34.7 | 8.4 | 41 | 34.3 | 8.2 | 0.85 | 0.86 |
log10VL | c/ml | 83 | 4.5 | 0.8 | 42 | 5.2 | 0.3 | 41 | 3.9 | 0.6 | n/a | n/a |
Immunology markers: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   CD4+ T cell count | cells/mm3 | 83 | 260.8 | 53.9 | 42 | 249.0 | 50.7 | 41 | 272.9 | 54.9 | 0.04 | 0.14 |
   CD8+ T cell count | cells/mm3 | 59 | 814.0 | 484.0 | 29 | 874.6 | 560.8 | 30 | 755.4 | 397.1 | 0.35 | 0.51 |
   % CD38+ CD4+ T cells | % of CD4 | 60 | 75.5 | 11.3 | 30 | 79.0 | 9.0 | 30 | 72.0 | 12.3 | 0.02 | 0.1 |
   % CD38+ CD8+ T cells | % of CD8 | 60 | 87.0 | 11.2 | 30 | 91.1 | 7.8 | 30 | 82.8 | 12.6 | 0.0034 | 0.1 |
   % HLA-DR+ CD4+ T cells | % of CD4 | 60 | 26.25 | 9.71 | 30 | 29.5 | 10.04 | 30 | 23.0 | 8.3 | 0.0090 | 0.1 |
   % HLA-DR+ CD8+ T cells | % of CD8 | 60 | 56.4 | 14.3 | 30 | 59.6 | 14.6 | 30 | 53.2 | 13.4 | 0.08 | 0.1 |
   % CD95+ CD4+ T cells | % of CD4 | 60 | 78.5 | 10.9 | 30 | 80.6 | 10.9 | 30 | 76.4 | 10.6 | 0.13 | 0.28 |
   % CD95+ CD8+ T cells | % of CD8 | 60 | 60.6 | 7.2 | 30 | 60.4 | 6.1 | 30 | 60.8 | 8.3 | 0.84 | 0.86 |
   % CD28+ CD4++T cells | % of CD4 | 60 | 80.7 | 11.1 | 30 | 80.1 | 10.7 | 30 | 81.2 | 11.7 | 0.70 | 0.82 |
   % CD28+ CD8+ T cells | % of CD8 | 60 | 30.8 | 9.3 | 30 | 30.3 | 9.7 | 30 | 31.3 | 9.1 | 0.68 | 0.82 |
   Total NK cells | cells/mm3 | 59 | 12.9 | 10.2 | 29 | 14.4 | 12.9 | 30 | 11.5 | 6.6 | 0.28 | 0.46 |
   % CD56+/CD16+ cells | % of NK | 60 | 54.9 | 20.1 | 30 | 50.4 | 18.8 | 30 | 59.4 | 20.6 | 0.08 | 0.1 |
   % CD56+/CD16- NK cells | % of NK | 60 | 22.1 | 16.2 | 30 | 23.4 | 17.6 | 30 | 20.9 | 14.9 | 0.55 | 0.74 |
   % HLA-DR+ total NK cells | % of NK | 60 | 19.9 | 16.8 | 30 | 22.2 | 17.9 | 30 | 17.6 | 15.6 | 0.29 | 0.46 |
   % HLA-DR+ CD56+/CD16+ NK cells | % of NK | 60 | 23.0 | 20.8 | 30 | 26.2 | 22.7 | 30 | 19.7 | 18.6 | 0.23 | 0.4 |
   Plasmacytoid dendritic cells | cells/mm3 | 58 | 0.2 | 0.1 | 28 | 0.1 | 0.1 | 30 | 0.2 | 0.1 | 0.18 | 0.37 |
   Myeloid dendritic cells | cells/mm3 | 59 | 0.5 | 0.8 | 29 | 0.5 | 0.6 | 30 | 0.5 | 1.0 | 0.86 | 0.86 |
Adipose tissue-associated variables: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Body mass index (BMI) | kg/m2 | 82 | 27.4 | 7.1 | 41 | 25.6 | 6.4 | 41 | 29.2 | 7.4 | 0.02 | 0.1 |
   Waist circumference | cm | 83 | 83.9 | 14.9 | 42 | 80.2 | 13.4 | 41 | 87.6 | 15.5 | 0.02 | 0.1 |
   Subcutaneous abdominal fat (MRI) | cm2 | 81 | 338.8 | 195.9 | 42 | 294.2 | 185.9 | 39 | 386.9 | 197.3 | 0.03 | 0.12 |
   Visceral abdominal fat (MRI) | cm2 | 81 | 51.5 | 30.4 | 42 | 47.3 | 28.8 | 39 | 56.1 | 31.9 | 0.20 | 0.37 |
   Perirenal hilar fat (MRI) | cm2 | 81 | 5.7 | 3.1 | 42 | 5.5 | 3.4 | 39 | 6.0 | 2.8 | 0.40 | 0.56 |
   Total fat mass (DEXA) | kg | 80 | 26.2 | 12.2 | 41 | 24.1 | 11.9 | 39 | 28.5 | 12.2 | 0.11 | 0.28 |
   Total lean mass (DEXA) | kg | 80 | 40.9 | 5.9 | 41 | 39.8 | 54.4 | 39 | 42.1 | 6.1 | 0.09 | 0.26 |
   Leg fat mass (DEXA) | kg | 80 | 11.6 | 5.6 | 41 | 10.8 | 4.5 | 39 | 12.5 | 6.5 | 0.20 | 0.37 |
   Trunk fat mass (DEXA) | kg | 80 | 10.4 | 6.1 | 41 | 9.4 | 6 | 39 | 11.5 | 6 | 0.03 | 0.12 |
   Weight | kg | 83 | 70.2 | 17.9 | 42 | 67.2 | 17.1 | 41 | 73.2 | 18.3 | 0.12 | 0.28 |
   Reported weight loss | % true | 83 | 38 | n/a | 42 | 40 | n/a | 41 | 36.7 | n/a | 0.86*** | 0.86 |
   Leptin | ng/ml | 66 | 28.3 | 17.6 | 33 | 23.4 | 17.7 | 33 | 33.3 | 16.3 | 0.02 | 0.1 |
   Triglycerides | mmol/l | 77 | 0.9 | 0.4 | 38 | 0.9 | 0.3 | 39 | 0.9 | 0.4 | 0.57 | 0.74 |
   LDL-associated cholesterol | mmol/l | 77 | 2.3 | 0.8 | 38 | 2.2 | 0.6 | 39 | 2.3 | 0.9 | 0.62 | 0.78 |
   Free fatty acids | mmol/l | 66 | 0.5 | 0.2 | 33 | 0.5 | 0.2 | 33 | 0.4 | 0.3 | 0.31 | 0.47 |
   Glucose | mmol/l | 74 | 4.3 | 0.4 | 37 | 4.3 | 0.4 | 37 | 4.3 | 0.4 | 0.75 | 0.85 |
   HOMA2-IR | n/a | 67 | 0.9 | 0.5 | 32 | 0.8 | 0.4 | 35 | 1.0 | 0.6 | 0.10 | 0.27 |